Ventricular Assist Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Ventricular Assist Device Market covers analysis By By Product (Biventricular assist devices, Left ventricular assist devices, Right ventricular assist devices), By Type (Implantable ventricular assist devices, Transcutaneous ventricular assist devices), By Application (Destination therapy, Bridge-to-recovery therapy, Bridge-to-transplant therapy, Bridge-to-candidacy therapy), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPMD00002249
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. In some instances VAD's are also used as destination therapy (DT). In this instance, the patient shall not undergo a heart transplantation and the VAD is what the patient will use for the remainder of his life.

The market of ventricular assist device market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence and incidence of patients with heart failure, increasing prevalence of cardiovascular diseases and shortage of heart donors. Furthermore, the development of technology in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the market. Conversely, specific limitations of these devices like high cost and serious risks tangled with implantation procedure of a ventricular assist device restrict the market growth.

The "Global Ventricular Assist Device Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global ventricular assist device market with detailed market segmentation by product, type, application, and geography. The global ventricular assist device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global ventricular assist device market is segmented on the basis of product, technology, End User, and Geography. The product segment includes, Biventricular Assist Devices, Left Ventricular Assist Devices, and Right Ventricular Assist Devices. Based on type, the market is segmented as, Implantable Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices. Based on application, the market is segmented as, Destination therapy, Bridge-to-recovery therapy, Bridge-to-transplant therapy, Bridge-to-candidacy therapy
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global ventricular assist device market based on product, type, application, and geography. It also provides market size and forecast till 2031 for overall ventricular assist device market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is estimated to contribute to the largest share in the Ventricular Assist Device Market in the coming years, owing to factors such as, enhanced infrastructure of healthcare and increasing number of patients with heart failure due to increased consumption of unhealthy food in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry, rise in number of cardiovascular diseases in Asian countries such as, India, China and Japan.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key ventricular assist device market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are CardiacAssist, Inc, Jarvik Heart, Inc., ABIOMED, Thoratec Corporation, Berlin Heart, ReliantHeart, Inc., TERUMO CORPORATION, Calon Cardio, HeartWare International, Medtronic Plc.

Ventricular Assist Device Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Biventricular assist devices
  • Left ventricular assist devices
  • Right ventricular assist devices
By Type
  • Implantable ventricular assist devices
  • Transcutaneous ventricular assist devices
By Application
  • Destination therapy
  • Bridge-to-recovery therapy
  • Bridge-to-transplant therapy
  • Bridge-to-candidacy therapy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CARDIACASSIST, INC
  • JARVIK HEART, INC.
  • ABIOMED
  • THORATEC CORPORATION
  • BERLIN HEART
  • RELIANTHEART, INC.
  • TERUMO CORPORATION
  • CALON CARDIO
  • HEARTWARE INTERNATIONAL
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    • CARDIACASSIST, INC
    • JARVIK HEART, INC.
    • ABIOMED
    • THORATEC CORPORATION
    • BERLIN HEART
    • RELIANTHEART, INC.
    • TERUMO CORPORATION
    • CALON CARDIO
    • HEARTWARE INTERNATIONAL
    • MEDTRONIC PLC.

    Buy Now